APELLIS PHARMACEUTICALS INC's ticker is and the CUSIP is 03753UAB2. A total of 23 filers reported holding APELLIS PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,511,675 | -75.5% | 1,195,000 | -53.7% | 0.00% | -100.0% |
| Q2 2023 | $6,164,667 | +3145138.3% | 2,581,000 | +1885.4% | 0.00% | – |
| Q4 2022 | $196 | -100.0% | 130,000 | -87.3% | 0.00% | – |
| Q3 2022 | $1,937,000 | +1293.5% | 1,025,000 | +1002.2% | 0.00% | – |
| Q2 2022 | $139,000 | -96.8% | 93,000 | -96.8% | 0.00% | -100.0% |
| Q4 2021 | $4,366,000 | +36.1% | 2,884,000 | +9.7% | 0.00% | – |
| Q3 2021 | $3,207,000 | -76.9% | 2,629,000 | -73.6% | 0.00% | -100.0% |
| Q1 2021 | $13,902,000 | +2.4% | 9,944,000 | +21.1% | 0.00% | 0.0% |
| Q4 2020 | $13,576,000 | +826.7% | 8,214,000 | +494.4% | 0.00% | – |
| Q3 2020 | $1,465,000 | – | 1,382,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 28,825,000 | $35,498,000 | 0.69% |
| DeepCurrents Investment Group LLC | 15,079,000 | $18,525,000 | 0.55% |
| WOLVERINE ASSET MANAGEMENT LLC | 33,996,000 | $41,869,000 | 0.36% |
| Weiss Asset Management LP | 9,000,000 | $10,980,000 | 0.28% |
| SSI INVESTMENT MANAGEMENT LLC | 3,418,000 | $4,192,000 | 0.25% |
| Baker Brothers Advisors | 46,754,000 | $57,262,000 | 0.25% |
| MACKAY SHIELDS LLC | 15,855,000 | $19,641,000 | 0.18% |
| Verition Fund Management LLC | 4,310,000 | $5,350,000 | 0.05% |
| WESTWOOD HOLDINGS GROUP INC | 1,000,000 | $1,236,000 | 0.01% |
| GIRARD PARTNERS LTD. | 66,081 | $162,000 | 0.01% |